Colorectal Cancer

CASC15[LncRNA]

miR-582-5p[miRNA]

HMGB2[mRNA]

colorectal cancer cells

Homo sapiens (human)

J Gene Med. 2021 Jan 4:e3308. doi: 10.1002/jgm.3308.

Tumor promoting long non-coding RNA CASC15 affects HMGB2 expression by sponging miR-582-5p in colorectal cancer.

qRT-PCR;Luciferase activity assay;

BACKGROUND: The importance of long non-coding RNAs (lncRNAs) in regulating tumorigenesis has been gradually recognized. Roles of lncRNA cancer susceptibility candidate 15 (CASC15) in cancers have been validated by several independent groups, however, its role in colorectal cancer (CRC) remains to be explored. METHODS: Levels of CASC15 in CRC cells and normal cells were measured with the qRT-PCR method. In vitro functional assays were performed to detect the effects of CASC15 on cell proliferation, invasion, and apoptosis. Bioinformatic analyses and luciferase activity assays were conducted to investigate the targets for CASC15. Animal experiments were conducted to analyze the effect of CASC15 on tumor growth in vivo. RESULTS: CASC15 level is revealed to be significantly elevated in CRC cells compared with normal cells. In vitro assays revealed that CASC15 overexpression stimulates cell growth and invasion, while its down-expression has opposite effects. Furthermore, CASC15 can bind with microRNA-582-5p (miR-582-5p) to modulate high mobility group box 2 (HMGB2) expression. We also showed that silencing of CASC15 inhibits tumor growth. CONCLUSIONS: In summary, CASC15 overexpression could promote CRC carcinogenesis, indicating knockdown of CASC15 might be a possible therapeutic measure to hinder carcinogenesis. This work could help us to understand the mechanisms behind CRC progression.